Literature DB >> 18391841

The arginine-creatine pathway is disturbed in children and adolescents with renal transplants.

Fernando Andrade1, Juan Rodríguez-Soriano, José Angel Prieto, Javier Elorz, Mireia Aguirre, Gema Ariceta, Sergio Martin, Pablo Sanjurjo, Luis Aldámiz-Echevarría.   

Abstract

Cardiovascular disease is an important cause of morbidity in recipients of renal transplants. The aim of the present study was to analyze the status of the arginine-creatine pathway in such patients, given the relationship between the arginine metabolism and both renal function and the methionine-homocysteine cycle. Twenty-nine children and adolescents (median age 13, range 6-18 years), who had received a renal allograft 14.5-82.0 months before, were recruited for the study. On immunosuppressive therapy, all patients evidenced an adequate level of renal function. Plasma concentrations of homocysteine and glycine were significantly higher, whereas urinary excretions of guanidinoacetate and creatine were significantly lower than controls. Urinary excretions of guanidinoacetate and creatine correlated positively with creatinine clearance. Urinary excretion of creatine was negatively correlated with plasma concentration of homocysteine. The demonstration of disturbances in the arginine-creatine pathway in patients with well-functioning renal transplants and in absence of chronic renal failure represents a novel finding. We speculate that the low urinary excretion of guanidinoacetate and creatine is probably related to the nephrotoxic effect of immunosuppressive therapy and to defective methylation associated with the presence of hyperhomocysteinemia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18391841     DOI: 10.1203/PDR.0b013e318176180e

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  2 in total

1.  Amino acids in a targeted versus a non-targeted metabolomics LC-MS/MS assay. Are the results consistent?

Authors:  Jacek Klepacki; Jost Klawitter; Jelena Klawitter; Anis Karimpour-Fard; Joshua Thurman; Gordon Ingle; Dharmesh Patel; Uwe Christians
Journal:  Clin Biochem       Date:  2016-06-08       Impact factor: 3.281

2.  Targeted Next-Generation Sequencing in Patients with Suggestive X-Linked Intellectual Disability.

Authors:  Nekane Ibarluzea; Ana Belén de la Hoz; Olatz Villate; Isabel Llano; Intzane Ocio; Itxaso Martí; Miriam Guitart; Elisabeth Gabau; Fernando Andrade; Blanca Gener; María-Isabel Tejada
Journal:  Genes (Basel)       Date:  2020-01-02       Impact factor: 4.096

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.